Extended-Use, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor (PCSK9i) Data in Patients With Diabetes Mellitus: A Pharmacist-Led Initiative
Loading...
Issue Date
2017-05
Authors
Bizier, Joseph
Stryker, Matthew ++
Kane, Michael
Degree
Advisor
Committee Members
Journal Title
Journal ISSN
Volume Title
Abstract
Citation
Bizier, Joseph, et al. “Extended-Use, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor (PCSK9I) Data in Patients with Diabetes Mellitus: A Pharmacist-Led Initiative.” Journal of Clinical Lipidology, vol. 11, no. 3, 2017, p. 778., https://doi.org/10.1016/j.jacl.2017.04.014.
ACPHS Research Commons URI
Description
Click on the Resource Link to access the article (may not be free).